CD45 in human physiology and clinical medicine
A Rheinländer, B Schraven, U Bommhardt - Immunology letters, 2018 - Elsevier
CD45 is an evolutionary highly conserved receptor protein tyrosine phosphatase exclusively
expressed on all nucleated cells of the hematopoietic system. It is characterized by the …
expressed on all nucleated cells of the hematopoietic system. It is characterized by the …
Protein tyrosine phosphatases as potential therapeutic targets
Protein tyrosine phosphorylation is a key regulatory process in virtually all aspects of cellular
functions. Dysregulation of protein tyrosine phosphorylation is a major cause of human …
functions. Dysregulation of protein tyrosine phosphorylation is a major cause of human …
Astatine-211 based radionuclide therapy: Current clinical trial landscape
P Albertsson, T Bäck, K Bergmark, A Hallqvist… - Frontiers in …, 2023 - frontiersin.org
Astatine-211 (211At) has physical properties that make it one of the top candidates for use
as a radiation source for alpha particle-based radionuclide therapy, also referred to as …
as a radiation source for alpha particle-based radionuclide therapy, also referred to as …
Bismuth-213 for targeted radionuclide therapy: from atom to bedside
In contrast to external high energy photon or proton therapy, targeted radionuclide therapy
(TRNT) is a systemic cancer treatment allowing targeted irradiation of a primary tumor and …
(TRNT) is a systemic cancer treatment allowing targeted irradiation of a primary tumor and …
The potential and hurdles of targeted alpha therapy–clinical trials and beyond
J Elgqvist, S Frost, JP Pouget, P Albertsson - Frontiers in oncology, 2014 - frontiersin.org
This article presents a general discussion on what has been achieved so far and on the
possible future developments of targeted alpha (α)-particle therapy (TAT). Clinical …
possible future developments of targeted alpha (α)-particle therapy (TAT). Clinical …
A nuclear chocolate box: the periodic table of nuclear medicine
PJ Blower - Dalton Transactions, 2015 - pubs.rsc.org
Radioisotopes of elements from all parts of the periodic table find both clinical and research
applications in radionuclide molecular imaging and therapy (nuclear medicine). This article …
applications in radionuclide molecular imaging and therapy (nuclear medicine). This article …
[HTML][HTML] Expression of B-cell surface antigens in subpopulations of exosomes released from B-cell lymphoma cells
MP Oksvold, A Kullmann, L Forfang, B Kierulf, M Li… - Clinical …, 2014 - Elsevier
Purpose Exosomes are small (30-to 100-nm) vesicles secreted by all cell types in culture
and found in most body fluids. A mean of 1 mL of blood serum, derived from healthy donors …
and found in most body fluids. A mean of 1 mL of blood serum, derived from healthy donors …
Biomaterial-mediated internal radioisotope therapy
Radiation therapy (RT), including external beam radiotherapy (EBRT) and internal
radioisotope therapy (RIT), has been an indispensable strategy for cancer therapy in clinical …
radioisotope therapy (RIT), has been an indispensable strategy for cancer therapy in clinical …
Antibody pretargeting based on bioorthogonal click chemistry for cancer imaging and targeted radionuclide therapy
A Rondon, F Degoul - Bioconjugate Chemistry, 2019 - ACS Publications
Bioorthogonal click chemistry—employing antibody-conjugated trans-cyclooctenes (TCO)
and tetrazine (Tz)-based radioligands able to covalently bind in vivo—appeared recently as …
and tetrazine (Tz)-based radioligands able to covalently bind in vivo—appeared recently as …
Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry
The pretargeting system based on the inverse electron demand Diels-Alder reaction
(IEDDA) between trans-cyclooctene (TCO) and tetrazine (Tz) combines the favorable …
(IEDDA) between trans-cyclooctene (TCO) and tetrazine (Tz) combines the favorable …